PMID- 14678903 OWN - NLM STAT- MEDLINE DCOM- 20040422 LR - 20061115 IS - 1000-2588 (Print) IS - 1000-2588 (Linking) VI - 23 IP - 12 DP - 2003 Dec TI - [Association of autoantibody and cytokines with latent autoimmune diabetes in adults]. PG - 1323-5 AB - OBJECTIVE: To assess the clinical value of detecting glutamic acid decarboxylase antibody (GADA), islet cell antibody (ICA) and cytokines in the diagnosis of latent autoimmune diabetes in adults (LADA), and define the characteristics of the two different types of LADA. METHODS: A total of 500 patients with an initial diagnosis of type 2 diabetes mellitus (T2DM) were tested for GADA, ICA and cytokines by enzyme-linked immunosorbent assay. RESULTS: In type 2 diabetic patients approximately 11% were positive for GADA, who had similar symptoms as hypertension, hyperlipidemia and other diabetic complications to justify the diagnosis of LADA-2 subtype. Another 9.6% of the total patients were ICA-positive, and when compared with T2DM, these patients had similar clinical findings typical of type 1 diabetes such as younger age of onset, impaired beta cell function and dependence on insulin treatment. Therefore they had more resemblance to insulin-dependent diabetes and can be diagnosed as having LADA-1 subtype. It was also found that cytokines positively acted on GADA and ICA, showing positive correlation between them. CONCLUSION: LADA has LADA-1 and LADA-2 subtypes, and GADA, ICA and cytokines test have important clinical significance for diagnosis of LADA. FAU - He, Feng-Ping AU - He FP AD - Clinical Laboratory Center, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, China. LA - chi PT - English Abstract PT - Journal Article PL - China TA - Di Yi Jun Yi Da Xue Xue Bao JT - Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA JID - 9426110 RN - 0 (Autoantibodies) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (islet cell antibody) RN - EC 4.1.1.15 (Glutamate Decarboxylase) SB - IM MH - Adult MH - Aged MH - Autoantibodies/*blood MH - Diabetes Mellitus, Type 1/complications/*immunology MH - Female MH - Glutamate Decarboxylase/*immunology MH - Humans MH - Interleukin-6/*blood MH - Male MH - Middle Aged MH - Tumor Necrosis Factor-alpha/*analysis EDAT- 2003/12/18 05:00 MHDA- 2004/04/23 05:00 CRDT- 2003/12/18 05:00 PHST- 2003/12/18 05:00 [pubmed] PHST- 2004/04/23 05:00 [medline] PHST- 2003/12/18 05:00 [entrez] PST - ppublish SO - Di Yi Jun Yi Da Xue Xue Bao. 2003 Dec;23(12):1323-5.